VC
LKFT

Veracity Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Veracity Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,124
Closed -$416K – 252
2020
Q1 		$416K Sell
2,124
-218
-9% -$46.9K 0.12% 124
2019
Q4 		$484K Buy
+2,342
New +$433K 0.13% 126

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Veracity Capital's LKFT Position: Q2 2020 in Review

Veracity Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2020, closing a stake of 2,124 shares — an estimated $416K sold.

Veracity Capital first reported a position in LKFT in Q4 2019 and held it in 2 quarters. The position peaked at $484K in Q4 2019. 143 funds tracked by Wall St. Rank hold LKFT as of Q2 2020.

  • Veracity Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • Veracity Capital sold 2,124 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2020, an estimated $416K.
  • Veracity Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2019 and held it in 2 quarters.
  • Veracity Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $484K in Q4 2019.
  • 143 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2020.

Based on Veracity Capital's 13F filing for Q2 2020, filed 13 Jul 2020.